{
  "author": {
    "name": "Alicia Lai",
    "webUrl": "/author/profile/alicia-lai/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2021/05/14/the-fallacy-of-ip-waivers-411-25064/",
        "title": "The Fallacy of IP Waivers",
        "byline": "Osagie Imasogie & Alicia Lai",
        "kicker": "Analysis",
        "prettyDate": "May 14, 2021",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.treasuryandrisk.com/contrib/content/uploads/sites/411/2021/05/Covid-19-Vaccine-Mass-Production-Manufacture-Article-202105131533.jpg",
          "width": "621",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/osagie-imasogie/",
            "name": "Osagie Imasogie"
          },
          {
            "webUrl": "/author/profile/alicia-lai/",
            "name": "Alicia Lai"
          }
        ],
        "kickerNode": [
          {
            "uri": "/analysis/",
            "sectionName": "Analysis"
          }
        ],
        "summary": "Blunders in technology transfer to South Africa in the HIV/AIDS epidemic serve a cautionary tale for compulsory licensing in the Covid-19 pandemic.",
        "body": null
      }
    ]
  }
}